GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 1701 - 1750 of 39437 in total
PDB ID UniProt ID Title Descriptor ▲
5VOB Q68674 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB P16837 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB F5HCP3 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB F5HET4 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB S6B291 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB 5VOB Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB S6B291 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB 5VOB Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB Q6GMX0 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB Q6GMX0 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
6VLR Q2N0S6 BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab Envelope glycoprotein gp120, BG505 SOSIPv5.2 gp41, PGT122 Fab Heavy Chain, PGT122 Fab Light Chain, RM20E1 Fab Heavy Chain, RM20E1 Fab Kappa Chain
6VLR 6VLR BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab Envelope glycoprotein gp120, BG505 SOSIPv5.2 gp41, PGT122 Fab Heavy Chain, PGT122 Fab Light Chain, RM20E1 Fab Heavy Chain, RM20E1 Fab Kappa Chain
6N1W Q2N0S6 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain
6N1W 6N1W Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain
6N1W Q2N0S7 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain
6UM6 A0A1W6IPB2 Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41
6UM6 Q2N0S7 Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41
6UM6 6UM6 Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41
6VPX 6VPX Nanodisc of full-length HIV-1 Envelope glycoprotein clone AMC011 in complex with one PGT151 Fab and three 10E8 Fabs Envelope glycoprotein gp120, Envelope glycoprotein gp41, Antibody 10E8 Fab heavy chain, Antibody 10E8 Fab light chain, MPER peptide, Antibody PGT151 Fab heavy chain, Antibody PGT151 Fab light chain
6PW6 Q2N0S6 The HIV-1 Envelope Glycoprotein Clone BG505 SOSIP.664 in Complex with Three Copies of the Bovine Broadly Neutralizing Antibody, NC-Cow1, Fragment Antigen Binding Domain Envelope glycoprotein gp120, Envelope glycoprotein gp41, Broadly Neutralizing Antibody NC-Cow1 Heavy Chain
6PW6 6PW6 The HIV-1 Envelope Glycoprotein Clone BG505 SOSIP.664 in Complex with Three Copies of the Bovine Broadly Neutralizing Antibody, NC-Cow1, Fragment Antigen Binding Domain Envelope glycoprotein gp120, Envelope glycoprotein gp41, Broadly Neutralizing Antibody NC-Cow1 Heavy Chain
6OLP 6OLP Full length HIV-1 Env AMC011 in complex with PGT151 Fab Envelope glycoprotein gp120, Envelope glycoprotein gp41, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6VO3 6VO3 AMC009 SOSIP.v4.2 in complex with PGV04 Fab Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGV04 heavy chain, PGV04 light chain
6VO1 Q2N0S6 BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20J Envelope glycoprotein gp120, Envelope glycoprotein gp41, RM20J Heavy chain Fab, RM20J Kappa light chain
6VO1 6VO1 BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20J Envelope glycoprotein gp120, Envelope glycoprotein gp41, RM20J Heavy chain Fab, RM20J Kappa light chain
6NF2 Q2N0S6 Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, Envelope glycoprotein gp41, VRC03 Heavy Chain, VRC03 Light Chain, PGT122 Heavy Chain, PGT122 Light Chain, 0PV-c.01 Heavy Chain, 0PV-c.01 Light Chain
6NF2 6NF2 Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, Envelope glycoprotein gp41, VRC03 Heavy Chain, VRC03 Light Chain, PGT122 Heavy Chain, PGT122 Light Chain, 0PV-c.01 Heavy Chain, 0PV-c.01 Light Chain
6OSY Q2N0S6 Cryo-EM structure of vaccine-elicited antibody 0PV-a.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, Envelope glycoprotein gp41, VRC03 Heavy Chain, VRC03 Light Chain, PGT122 Heavy Chain, PGT122 Light Chain, 0PV-c.01 Heavy Chain, 0PV-c.01 Light Chain
6OSY 6OSY Cryo-EM structure of vaccine-elicited antibody 0PV-a.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, Envelope glycoprotein gp41, VRC03 Heavy Chain, VRC03 Light Chain, PGT122 Heavy Chain, PGT122 Light Chain, 0PV-c.01 Heavy Chain, 0PV-c.01 Light Chain
6OT1 6OT1 Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, Envelope glycoprotein gp41, VRC03 Heavy Chain, VRC03 Light Chain, PGT122 Heavy Chain, PGT122 Light Chain, 0PV-c.01 Heavy Chain, 0PV-c.01 Light Chain
6OT1 Q2N0S6 Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, Envelope glycoprotein gp41, VRC03 Heavy Chain, VRC03 Light Chain, PGT122 Heavy Chain, PGT122 Light Chain, 0PV-c.01 Heavy Chain, 0PV-c.01 Light Chain
7LO6 Q2N0S6 Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab Envelope glycoprotein gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, 17b Fab Light Chain, 17b Fab Heavy Chain
7LO6 7LO6 Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab Envelope glycoprotein gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, 17b Fab Light Chain, 17b Fab Heavy Chain
6OHY Q1A234 Chimpanzee SIV Env trimeric ectodomain. Envelope glycoprotein gp160
4DVX A0A0M3KKW9 Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with MAE-II-188 Envelope glycoprotein gp160
6OPO B3UES2 Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPO B3UEZ6 Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPO P01730 Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPO 6OPO Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPQ B3UES2 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPQ B3UEZ6 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPQ P01730 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPQ 6OPQ CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5B B3UES2 Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5B B3UEZ6 Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5B P01730 Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5B 6X5B Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5C B3UES2 Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5C B3UEZ6 Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5C P01730 Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024